Pay in 4 interest-free payments of $5.18 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
Key Takeaways Triple agonist mechanism: Retatrutide is the first medication to activate GIP, GLP-1, and glucagon receptors simultaneously GLP-1 component reduces appetite and slows gastric emptying, the core appetite suppression pathway GIP component improves insulin sensitivity and promotes favorable fat distribution Glucagon component increases energy expenditure through thermogenesis and promotes fat breakdown Weight loss: Phase 2 trials showed up to 24.2% weight loss at 48 weeks, compared to tirzepatide (~22%) and semaglutide (~15%) Investigational status: Not FDA-approved
A: Store the soap in a cool, dry place away from direct sunlight to preserve its effectiveness and extend shelf life
Cautions: If you are pregnant or nursing, consult your physician before taking this product.
Ro Body Ro separates its Body membership from the medication charge
US$ 20.74
US$ 25.55
US$ 22.45
US$ 20.02
US$ 26.14
US$ 21.12
